OTARSIS Trademark

Trademark Overview

On Tuesday, August 30, 2016, a trademark application was filed for OTARSIS with the United States Patent and Trademark Office. The USPTO has given the OTARSIS trademark a serial number of 87155772. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 8, 2018. This trademark is owned by Amgen Inc.. The OTARSIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith
otarsis

General Information

Serial Number87155772
Word MarkOTARSIS
Filing DateTuesday, August 30, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 8, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 6, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Tuesday, October 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 8, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 2, 2018EXTENSION 2 GRANTED
Friday, March 2, 2018EXTENSION 2 FILED
Friday, March 2, 2018TEAS EXTENSION RECEIVED
Wednesday, August 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2017EXTENSION 1 GRANTED
Monday, July 31, 2017EXTENSION 1 FILED
Monday, July 31, 2017TEAS EXTENSION RECEIVED
Wednesday, March 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 2, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 30, 2016ASSIGNED TO LIE
Thursday, November 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 17, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, November 17, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 17, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, November 17, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, October 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 28, 2016NON-FINAL ACTION E-MAILED
Friday, October 28, 2016NON-FINAL ACTION WRITTEN
Friday, October 28, 2016ASSIGNED TO EXAMINER
Tuesday, September 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 2, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

otarsis complications associated therewith disorders diseases preparations treatment oncological pharmaceutical